Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Folic Acid vs Omega-3: Omega-3 has the stronger overall evidence (9 vs 8/10); they're alternatives for prenatal support — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Omega-3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Probably helps
10 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (3)
Outcomes where both Folic Acid and Omega-3 have evidence — compare verdict strength side-by-side.
400 mcg/day for anyone planning or capable of pregnancy (USPSTF: 400-800 mcg); adult RDA 400 mcg DFE/day, 600 mcg DFE in pregnancy, 500 mcg DFE in lactation (IOM)
Any time of day
Folic acid (pteroylmonoglutamic acid)
2-3g combined EPA+DHA daily (a typical label dose, not the dose used in the cited trials, which gave 1 g or 3.25 g of omega-3 a day, or 1 to 4 g of fish oil a day without stating its EPA+DHA content)
With meals containing fat
Triglyceride form fish oil
Periconceptional
Weeks
Weeks to months
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
N Engl J Med (1992) · Rct
Randomised trial of periconceptional vitamin supplementation for prevention of a FIRST neural tube defect (PubMed publication types: Randomized Controlled Trial, Clinical Trial)
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.
Lancet (1991) · Rct
Randomised, multicentre trial of periconceptional folic acid for prevention of RECURRENT neural tube defects (PubMed publication types: Randomized Controlled Trial, Multicenter Study, Comparative Study)
Effects and safety of periconceptional oral folate supplementation for preventing birth defects.
Cochrane Database Syst Rev (2015) · Meta analysis
Cochrane Database of Systematic Reviews CD007950, third edition (PubMed publication types: Meta-Analysis, Systematic Review)
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
12 RCTs with 587 subjects: omega-3 supplementation increased serum BDNF versus placebo (SMD 0.72, 95% CI 0.28 to 1.15), with high heterogeneity (I2 = 84.39%).
The points are the dose bands of a meta-analysis of 10 randomised trials with 1,426 adults (PMID 37028202): EPA-rich products at 1 to under 2 g of EPA a day reduced depression severity (SMD -0.43), while 2 g a day or more did not (SMD -0.20, not significant), so the 2 g point is plotted as no effect. Doses are grams of EPA, not EPA plus DHA. The Cochrane review of 33 placebo-controlled trials found a small to modest effect, unlikely to be clinically meaningful and rated very low certainty, with no difference in remission or response (PMID 34817851). No trial compared doses directly.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 8/10) and wins in 3 of 3 categories.
For prenatal support, Folic Acid has a higher relevance score (95 vs 88).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Folate is essential; inositol + CoQ10 are the best bets — but conception evidence is limited.
Commonly recommended vs ask-your-clinician vs avoid — a general, safety-first overview.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.